# A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

> **NCT03530852** · NA · RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Short Bowel Syndrome
- Malabsorption

## Interventions

- **DEVICE:** Relizorb

## Key facts

- **NCT ID:** NCT03530852
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-11-21
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530852, "A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03530852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*